The Prostate Cancer Foundation (PCF) today announced that Howard R. Soule, Ph.D., will retire as PCF’s Chief Science Officer, ...
– 32nd Annual Scientific Retreat brought together 600+ prostate cancer researchers and leaders to spotlight breakthrough discoveries and advance cutting-edge science – – PCF continues to be the ...
LOS ANGELES--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) announced the recipients of its 2024 Challenge Awards, funding over $16 million in innovative prostate cancer research for ...
– Dr. Hussain was chosen for her extraordinary career in prostate cancer research, profound impact on patients, and mentorship of the next generation of prostate cancer researchers – – Award ...
BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...
Getty Images The American Cancer Society recommends that Black men discuss screening with their health care providers at age 45; the Prostate Cancer Foundation recommends prostate-specific antigen ...
Shenglin Mei of Virginia Tech's Fralin Biomedical Research Institute was part of a multi-institutional team including researchers from Harvard Medical School, Massachusetts General Hospital, the ...
Genitourinary medical oncologist Dr. Michael Morris is part of a new MSK program focused on better treatments for neuroendocrine cancers, which sometimes develop when prostate and lung cancers become ...
Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published Aug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback